Dorman Products
Dorman Products' revenue rose 6.0% to $2.1 billion in fiscal 2025. Its operating margin was 14.1%, down from 14.6% a year earlier. Free cash flow was $76 million, down 60.5%. The diluted share count fell 0.7%.
Operating margin is operating income as a share of revenue. Free cash flow is cash from operations minus capital spending. Return on capital is after-tax operating income as a share of the money invested in the business: debt plus equity, minus cash. Market cap is the last closing share price times the latest diluted share count, so it is approximate. P/E is the last close divided by diluted earnings per share over the last four quarters, or the latest fiscal year where the quarters aren't available; there is none when the company made a loss.
Charts show fiscal years, from the 10-K filings.
Revenue and margins
Net income and earnings per share
From fiscal 2016 to 2025, earnings per share grew 8.9% a year and net income 7.6% a year, as the share count fell by 11%.
Returns on capital
Cash flow
Payouts and share count
Valuation
Two ways to value Dorman Products yourself, both starting from its filings: a discounted cash flow model and the price-to-earnings method.
Discounted cash flow (DCF)
A discounted cash flow (DCF) model values a business as the cash it may generate in future, discounted back to today. The starting figures come from Dorman Products' 10-K (or, for net cash and shares, its latest 10-Q) and the assumptions are yours: start from one of three example scenarios, then change any figure to see what it implies for a share, and how that compares with the last share price.
Value per share on three example scenarios, from Dorman Products' fiscal 2025 free cash flow of $76M, net cash of −$391M at December 31, 2025 and 31 million diluted shares, from its filings. The scenarios are fitted to Dorman Products: the base scenario's growth in years 1 to 5 is its revenue growth over the last 3 years, 7.1% a year; the cautious and optimistic ones are lower and higher, and growth in years 6 to 10 is halfway to the long-run rate. The base scenario's discount rate is 12%: 11% for a cyclical or higher-risk business (Automotive Parts & Equipment), plus 1 point as a smaller company, worth $3.7B; the cautious and optimistic ones use a point more and a point less. Select one to load it into the calculator. These are the model's arithmetic on those assumptions, not a forecast or a price target.
- Last close, October 26, 2026
- $124.74
- Value on these assumptions, against the last close
- —
- Cash flows in years 1 to 10, valued today
- —
- Everything after year 10, valued today
- —
- Plus net cash
- —
- Share of value from after year 10
How the value changes with two assumptions
Price-to-earnings (P/E) method
Another common way to value a company is to multiply its earnings per share by a price-to-earnings (P/E) multiple: the number of years of today's earnings an investor pays for a share. A higher multiple usually means investors expect earnings to grow. Choose a multiple, for example from similar companies, to see the value it gives.
Value per share on three example scenarios, from Dorman Products' earnings per share of $7.22 (over the last four quarters). Each grows earnings for a year at the cash flow scenarios' rates and applies a multiple to next year's earnings: 17.3×, the middle of Dorman Products' own P/E today, its peers' median and its sector's median (Dorman Products' own P/E today) for the base scenario, 20% less and more for the cautious and optimistic ones. The price is brought back a year at 13%, 12% and 11%. Select one to load it into the calculator. These are the model's arithmetic on those assumptions, not a forecast or a price target.
- Last close, October 26, 2026
- $124.74
- Value at this multiple, against the last close
- —
- Dorman Products' P/E at the last close
- 17.3×
| Company | Last close | Earnings per share | P/E today |
|---|---|---|---|
| GenthermTHRM | $28.59 | $0.29 | 98.6× |
| Dorman ProductsDORM | $124.74 | $7.22 | 17.3× |
| Standard Motor ProductsSMP | $37.28 | $2.24 | 16.6× |
| GentexGNTX | $20.64 | $1.89 | 10.9× |
Balance sheet
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | 59 | 46 | 37 | 57 | 49 |
| Debt incl. finance leases | 0 | 495 | 483 | 469 | 441 |
| Net debt (negative means net cash) | −59 | 449 | 446 | 412 | 391 |
| Net debt to EBITDA | −0.3x | 2.2x | 1.8x | 1.3x | 1.2x |
| Debt to equity | 0.0x | 0.5x | 0.4x | 0.4x | 0.3x |
| Interest coverage | 79.3x | 11.0x | 4.5x | 7.4x | 10.5x |
| Current ratio | 1.6x | 1.9x | 2.2x | 2.4x | 3.1x |
| Quick ratio | 0.8x | 0.8x | 1.1x | 1.2x | 1.1x |
Insider trades
Over the 12 months between October 27, 2025 and October 26, 2026, no insider bought Dorman Products shares on the open market, and 4 insiders sold $3.4 million, $297,340 of it under trading plans set up in advance.
| Date | Insider | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Aug 17, 2026 | Donna M. LongSVP, CIO | Sold plan | 734 | $135.21 | $99,244 | Form 4 |
| Aug 5, 2026 | Gregory C. BowenVP, Chief Accounting Officer | Sold | 3,531 | $145.01 | $512,013 | Form 4 |
| Mar 12, 2026 | Donna M. LongSVP, CIO | Sold plan | 947 | $103.07 | $97,608 | Form 4 |
| Jan 2, 2026 | Donna M. LongSVP, CIO | Sold plan | 812 | $123.75 | $100,488 | Form 4 |
| Dec 12, 2025 | John McKnightPresident, Heavy Duty | Sold | 2,000 | $128.80 | $257,600 | Form 4 |
| Dec 1, 2025 | John McKnightPresident, Heavy Duty | Sold | 4,898 | $130.71 | $640,216 | Form 4 |
| Oct 31, 2025 | David HessionSVP and CFO | Sold | 12,493 | $135.31 | $1.7 million | Form 4 |
Piotroski F-score
The F-score counts how many of nine simple tests of profitability, funding and efficiency a company passed in a year (Piotroski, 2000). The more tests passed, the stronger the year: 8 or 9 is strong, 0 to 2 weak. Companies that report no gross profit are scored on the other eight.
| Test | FY23 | FY24 | FY25 |
|---|---|---|---|
| Net income is positive | Pass | Pass | Pass |
| Cash from operations is positive | Pass | Pass | Pass |
| Return on assets rose | Fail | Pass | Pass |
| Cash from operations exceeds net income | Pass | Pass | Fail |
| Debt fell relative to assets | Pass | Pass | Pass |
| Current ratio rose | Pass | Pass | Pass |
| Share count didn't rise | Pass | Pass | Pass |
| Gross margin rose | Pass | Pass | Pass |
| Revenue rose relative to assets | Fail | Pass | Pass |
| F-score | 7 of 9 | 9 of 9 | 8 of 9 |
| Accruals ratio | −3.4% | −1.7% | 3.7% |
Compare
Put Dorman Products side by side with any other company we cover: revenue, growth, margins, cash flow and returns, with ten years of charts.
Similar companies
| Company | Year | Revenue growth | Operating margin | Free cash flow margin | Return on capital | Net debt to EBITDA | F-score | Compare |
|---|---|---|---|---|---|---|---|---|
| Dorman Products | FY25 | 6.0% | 14.1% | 3.5% | 12.4% | 1.2x | 8 | |
| Mobileye | FY25 | 14.5% | −23.2% | 27.6% | — | — | — | Compare |
| Standard Motor Products | FY25 | 22.4% | 7.6% | 1.0% | 8.2% | 3.0x | 7 | Compare |
| Gentex | FY25 | 9.6% | 18.7% | 18.1% | 17.4% | −0.2x | 6 | Compare |
| Gentherm | FY25 | 2.9% | 5.5% | 4.1% | 5.8% | 0.2x | 6 | Compare |
10 years of figures
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | 860 | 903 | 974 | 991 | 1,093 | 1,345 | 1,734 | 1,930 | 2,009 | 2,130 |
| Revenue growth | 7.0% | 5.1% | 7.8% | 1.8% | 10.2% | 23.1% | 28.9% | 11.3% | 4.1% | 6.0% |
| Gross profit | 338 | 359 | 373 | 340 | 383 | 463 | 564 | 685 | 806 | 898 |
| Research and development | — | — | — | — | — | — | — | — | — | — |
| Operating income | 169 | 176 | 171 | 106 | 133 | 172 | 171 | 215 | 293 | 300 |
| Net income | 106 | 107 | 134 | 84 | 107 | 132 | 122 | 129 | 190 | 204 |
| Diluted EPS (US$) | 3.07 | 3.13 | 4.02 | 2.56 | 3.30 | 4.12 | 3.85 | 4.10 | 6.14 | 6.64 |
| Diluted shares (millions) | 35 | 34 | 33 | 33 | 32 | 32 | 32 | 32 | 31 | 31 |
| Cash flow | ||||||||||
| Cash from operations | 122 | 94 | 78 | 95 | 152 | 100 | 42 | 209 | 231 | 114 |
| Capital expenditure | 20 | 24 | 26 | 30 | 15 | 20 | 38 | 44 | 39 | 38 |
| Free cash flow | 101 | 70 | 52 | 66 | 137 | 80 | 4 | 165 | 192 | 76 |
| Dividends paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share buybacks | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Acquisitions | 0 | 60 | 28 | 0 | 15 | 346 | 489 | 0 | 0 | 0 |
| Stock-based compensation | 2 | 3 | 4 | 3 | 8 | 8 | 9 | 12 | 15 | 20 |
| Balance sheet at fiscal year end | ||||||||||
| Cash and short-term investments | 149 | 72 | 44 | 68 | 156 | 59 | 46 | 37 | 57 | 49 |
| Debt incl. finance leases | — | — | — | — | — | 0 | 495 | 483 | 469 | 441 |
| Total assets | 712 | 766 | 978 | 1,041 | 1,221 | 1,673 | 2,342 | 2,292 | 2,424 | 2,493 |
| Total liabilities | 110 | 131 | 250 | 268 | 367 | 740 | 1,299 | 1,124 | 1,131 | 1,016 |
| Shareholders' equity | 602 | 635 | 728 | 774 | 854 | 933 | 1,043 | 1,168 | 1,294 | 1,477 |
| Margins and ratios | ||||||||||
| Gross margin | 39.3% | 39.7% | 38.3% | 34.3% | 35.1% | 34.4% | 32.6% | 35.5% | 40.1% | 42.1% |
| Operating margin | 19.6% | 19.5% | 17.6% | 10.7% | 12.2% | 12.8% | 9.9% | 11.1% | 14.6% | 14.1% |
| Net margin | 12.3% | 11.8% | 13.7% | 8.4% | 9.8% | 9.8% | 7.0% | 6.7% | 9.5% | 9.6% |
| Free cash flow margin | 11.8% | 7.7% | 5.3% | 6.6% | 12.5% | 6.0% | 0.2% | 8.5% | 9.5% | 3.5% |
| Return on capital | — | — | — | — | — | — | 11.2% | 10.6% | 13.1% | 12.4% |
| Return on equity | 18.9% | 17.2% | 19.6% | 11.2% | 13.1% | 14.7% | 12.3% | 11.7% | 15.4% | 14.7% |
| Return on assets | 15.9% | 14.4% | 15.3% | 8.3% | 9.4% | 9.1% | 6.0% | 5.6% | 8.1% | 8.3% |
| Net debt to EBITDA | — | — | — | — | — | −0.3x | 2.2x | 1.8x | 1.3x | 1.2x |